Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]    
Collaboration revenue $ 18,626 $ 147,805
Operating expenses:    
Research and development 5,737,252 11,814,690
General and administrative 6,130,845 7,125,732
Total operating expense 11,868,097 18,940,422
Loss from operations (11,849,471) (18,792,617)
Foreign exchange gain (loss) 84,293 (40,077)
Other income 4,327,946
Net loss $ (7,437,232) $ (18,832,694)
Per share information:    
Net loss per share, basic $ (11.35) $ (145.13)
Net loss per share, diluted $ (11.35) $ (145.13)
Weighted average shares outstanding, basic 655,240 129,760
Weighted average shares outstanding, diluted 655,240 129,760